Targeting Peroxisome Proliferator-activated Receptor-gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?
Clinical trial NCT00516880 · UNKNOWN
Trial details
- NCT number
- NCT00516880
- Sponsor
- Hospital Authority, Hong Kong
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.